Document:

exhibit105

     Exhibit 10.5  SEPARATION AND GENERAL RELEASE AGREEMENT   This Separation And General Release Agreement (this “Agreement”) is entered by and  between James Sharman (“Executive”) and Norvax, LLC, its direct and indirect parent, and each  of its subsidiaries and affiliates (collectively, the “Company”) (collectively, the “Parties”).   In consideration of the mutual promises contained herein, including but not limited to the  General Release and Waiver and Covenant Not to Sue, the parties agree as follows:     1. Transitional Role / Separation from Employment / Final Compensation.        a. The parties mutually agree to change Executive’s position to a  Transitional Role as referred to in Executive’s Employment Agreement letter  dated June 6, 2020 (the “Employment Agreement”) beginning June 6, 2022  through August 31, 2022.  During the period in which Executive is employed  in a Transitional Role, Executive shall provide no more than 20 hours per week  of work, and Executive’s annual salary shall be $225,000per year. For the  avoidance of doubt, the Parties agree that the Change of Control provisions as  set forth in the Employment Agreement shall continue during the period in  which Executive is employed in a Transitional Role.      b. Executive will provide advice to the Company’s senior management  on matters within Executive’s areas of expertise and prior experience, including  with (i) the transition of Executive’s duties, and (ii) specific projects as directed  by the Company’s Chief Executive Officer or the Chief Executive Officer’s  designee. Company shall determine the scope of the work to be performed, but  Executive shall have the ability to select the means, manner and method of  performing these services. Executive, however, agrees to use his best efforts to  promote Company’s interests, and to give Company the benefit of his  experience, knowledge, and skills. Executive undertakes to perform services in  a timely and professional manner and to devote such time, attention and skill to  his duties under this Agreement as may reasonably be necessary to ensure the  performance of the Services to the Company Chief Executive Officer’s or the  Chief Executive Officer’s designee’s satisfaction.  Nothing herein shall be  deemed to preclude Company from retaining the services of other persons or  entities undertaking the same or similar services as those undertaken by  Executive hereunder.       c. Executive’s employment with the Company will end effective as of  September 1, 2022 (the “Separation Date”).  Executive will be paid for all  compensation earned by Executive through the Separation Date, including all  salary or wages, all accrued, unused paid time off due to Executive, and any  expenses owed to the Executive in accordance with the Company’s policies and  applicable law, and any amount arising from the Executive’s participation in,  

 

   -2-    or benefits under, any Executive benefit plans, programs or arrangements under  Section 3(c), which amounts shall be payable in accordance with the terms and  conditions of such Executive benefit plans, programs or arrangements.             2. No Further Compensation or Benefits / Vested Equity.     a) Except as expressly provided herein or as required by law, as of the  Separation Date, Executive shall no longer be entitled to receive any  compensation or benefits from the Company or to participate in any of the  Company’s benefit plans, and Executive expressly waives any and all rights  or claims (if any) to do so.   b) Except for Executive’s unvested Service Units as defined in that    Amendment No. 1 to the Executive Common Unit and Profits Unit   Agreement dated July 6, 2020 (the “Profits Unit Agreement”), which shall  become fully and immediately vested as of the Separation Date in  accordance with the Profits Unit Agreement, Executive acknowledges and  agrees that there are no other unvested equity or equity-type awards  (including, without limitation, restricted stock, restricted stock units, stock  options, stock appreciation rights or phantom equity) that have been granted  to Executive and that would otherwise vest on or after the Separation Date  or that are otherwise owed to Executive and any potential claims to such  other equity or equity-type awards are canceled, terminated and forfeited by  operation of this Agreement.  Executive agrees that, to the extent any RSU  Awards or Option Awards are not vested as of the Separation Date, they are  immediately forfeited. Executive further agrees that any outstanding vested  restricted stock units and/or stock options as of the Separation Date remain  subject to the terms of the 2020 Incentive Award Plan and the applicable  Award Agreement.    3. Separation Package / Consideration.  In consideration of the agreements and  covenants set forth in this Agreement, the Company offers Executive the compensation and  benefits described in this Paragraph 3 (the “Separation Package”).   a) Separation Payment.  In accordance with the terms of Executive’s  Employment Agreement, if Executive executes this Agreement and does  not timely revoke Executive’s signature or subsequently breach any  applicable terms, conditions or covenants contained in this Agreement, the  Company agrees to pay to Executive twelve (12) months of base salary, in  the total gross amount of Four Hundred Fifty Thousand ($450,000.00), less  applicable taxes and withholdings (the “Separation Payment”), which shall  be payable in equal installments over a twelve month period in conjunction  

 

   -3-    with the Company’s ordinary payrolls, beginning on the first regularly  scheduled payroll date twenty-nine (29) days after Executive signs, and  does not revoke, it.   b) Health Plan Coverage / COBRA Continuation Coverage Payments. In  accordance with the terms of the Employment Agreement, beginning on the  Separation Date and ending on the one (1) year anniversary of the   Separation Date, the Company will continue Executive’s coverage under  the Company’s group health plan under the same terms and conditions that  existed for the term of employment.  After the one (1) year anniversary of  the Separation Date, the Company will, until the Executive reaches age 65  and to the extent permitted by the Company’s group health plan and  applicable law, continue all the Executive’s coverage under the Company’s  group health plan if the Executive elects to continue coverage under the   Company’s group health plan in accordance with the Consolidated   Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”).  In  the event Executive elects to continue with COBRA coverage, such  coverage will be at the sole expense of the Executive. In the event Executive  obtains other employment that offers group health benefits, such  continuation of COBRA coverage by the Company under this Section  5(b)(iii) shall immediately cease.   c) Bonus Payout.  If Executive executes this Agreement and does not timely  revoke Executive’s signature or subsequently breach any applicable terms,  conditions or covenants contained in this Agreement, Executive shall  receive a prorated portion of his bonus based on the number of full months  for which Executive was employed during 2022, notwithstanding the  program requirement that Executive remain employed on the bonus  payment date (the “Bonus Payment”).  The bonus amount (if any) shall be  determined and paid in accordance with the Company’s terms.   d) Acknowledgment of Benefits / Consideration.  Executive agrees and  acknowledges that the Separation Payment and eligibility for the Bonus  Payment, described above at subparts (a) and (c), collectively constitute the  Separation Package.   Executive further agrees and acknowledges that the  Separation Package is above and beyond that to which Executive would  otherwise be entitled, including pursuant to any Company policy, practice  or plan addressing bonuses, incentives, awards or any other compensation,  and thus constitutes valid consideration in support of this Agreement,  specifically including but not limited to Executive’s release of claims.   Executive agrees and acknowledges that Executive has no entitlement to  receive any or all of this Separation Package, unless Executive enters into  this Agreement.  Executive further agrees and acknowledges that Executive  is not and shall not be entitled to any additional payments or benefits of any  kind that are not expressly provided for in this Agreement. Executive further  agrees and acknowledges that the Company reserves the right to discontinue  and recoup the Separation Package in the event Executive breaches any of  

 

   -4-    the terms or conditions of this Agreement.  Executive shall be solely and  exclusively responsible for any taxes or liabilities relating to Executive’s  receipt of the Separation Package (or any portion thereof).   4. Released Parties.  The term “Released Parties,” as used in this Agreement, shall  mean the Company and any of its past or present partners, principals, agents, employees,  representatives, administrators, agents, officials, officers, directors, shareholders, divisions,  parents, subsidiaries, successors, affiliates, related entities, consultants, employee benefit plans  (and their sponsors, fiduciaries, or administrators), insurers, and/or attorneys.  Without limiting the  scope and application of the foregoing definition of Released Parties, Executive acknowledges and  agrees that the Released Parties include (but are not limited to) Norvax, LLC, GoHealth, LLC and  their respective affiliates, officers, employees and agents.   5. General Release.  In consideration of the Separation Package described in  Paragraph 3 and other promises and covenants described in this Agreement, the receipt and  sufficiency of which Executive acknowledges, Executive, on behalf of Executive and Executive’s  agents, representatives, attorneys, assigns, heirs, executors, and administrators, fully releases each  of the Released Parties from any and all liability, claims, demands, actions, causes of action, suits,  grievances, debts, sums of money, agreements, promises, damages, back and front pay, costs,  expenses, attorneys’ fees, and remedies of any type, regarding any act or failure to act that occurred  up to and including the date on which Executive signs this Agreement, including, without  limitation, any claims arising or that arose or may have arisen out of or in connection with  Executive’s employment, or Executive’s separation of employment from the Company, and  including but not limited to:    a) All claims under the Age Discrimination in Employment Act (29 U.S.C.  §§621 et seq.), the Older Workers Benefit Protection Act, Title VII of the  Civil Rights Act of 1964, Sections 1981 through 1988 of Title 42 of the  United States Code, the Americans with Disabilities Act, the Family &  Medical Leave Act, the Fair Labor Standards Act, the Illinois Human Rights  Act, the Illinois Wage Payment and Collection Act, the Illinois Minimum  Wage Law, and/or any other federal, state or local law, ordinance or  regulation dealing in any respect with employment and/or discrimination,  leaves of absence, return to work and/or employment reinstatement, and/or  harassment or retaliation in employment;   b) All claims for compensation, severance pay, bonus, commission, or  incentive pay, paid time off, vacation pay and/or benefits of any kind (other  than any claims for unemployment compensation benefits),  including, but  not limited to, any and all unvested restricted stock units and/or stock  options granted pursuant to any applicable award agreements under the  Company’s Plan, which are forfeited in accordance with the 2020 Incentive  Award Plan’s terms, the terms of such award agreements and this  Agreement;    c) All claims under any common law contract or promise, whether written or  oral, express or implied, including, without limitation under any alleged  

 

   -5-    express or implied employment contract, agreement (but in no way  diminishing or impacting Executive’s continuing obligations under any  confidentiality-related and/or other restrictive covenant agreements  Executive may have signed) or other relationship or promise of any kind,  whistleblower or retaliation, tort or other theory; and   d) All claims arising under the Employee Retirement Income Security Act of  1974, as amended, including, without limitation any claims arising out of  the Company’s failure to provide timely notice to Executive regarding  Executive’s right to continue health care coverage.   In addition to the above-described release, Executive agrees and acknowledges that Executive: (i)  has not suffered any type of industrial or work-related injury as a result of employment with the  Company; (ii) does not possess any claim for unpaid wages, overtime, benefits or any other form  of compensation and has not filed any such claim with the Department of Labor or any other  administrative agency or court of law; (iii) has not filed any complaints, charges, applications or  lawsuits against the Company with any governmental agency or court, whether formally or  informally, and whether in Executive’s own name, anonymously, and/or by, though, and/or in  connection with any other person or entity; and (iv) has not assigned or otherwise transferred any  rights or interests in any actual or potential claims Executive might ever have asserted against the  Company or any of the Released Parties.      Executive further understands that this Agreement applies broadly to extinguish any and all claims  of the type described above, including, without limitation, any damages of any type (including,  without limitation, attorneys’ fees and costs) associated with or arising out of any such claims.  It  does not, however, include or apply to any claims that are not waivable pursuant to applicable law  or that arise after the date on which Executive signs this Agreement.  Nothing in this Agreement  shall prohibit Executive from reporting possible violations of federal law or regulation to any  governmental agency or entity, including but not limited to the Securities and Exchange  Commission in relation to Rule 21F, or making other disclosures that are protected under the  whistleblower provisions of federal law or regulation.  Executive agrees and acknowledges that  Executive does not need the prior authorization of the Released Parties to make such reports or  disclosure, and that Executive is not required to notify the Released Parties that Executive has  made such reports or disclosures.  Pursuant to 18 U.S.C. § 1833(b), Executive understands that  Executive shall not be held criminally or civilly liable under any federal or state trade secret law  for the disclosure of a trade secret that is made in confidence to a federal, state, or local government  official or to any attorney solely for the purpose of reporting or investigating a suspected violation  of law.  Executive shall not be held criminally or civilly liable under any federal or state trade  secret law for the disclosure of a trade secret that is made in a complaint or other document filed  in a lawsuit or other proceeding, if such filing is made under seal.  If Executive files a lawsuit for  retaliation by the Released Parties for reporting a suspected violation of law, Executive may  disclose the trade secret to Executive’s attorney and use the trade secret information in the court  proceeding, provided that Executive files any document containing the trade secret under seal, and  Executive does not otherwise disclose the trade secret, except pursuant to court order.      6. Covenant Not To Sue.  Except for an action arising out of a breach of the terms of  this Agreement, Executive agrees never to bring (or cause to be brought) any claim, action or  

 

   -6-    proceeding against the Company or any of the Released Parties regarding any act or failure to act  that occurred up to and including the date on which the Parties sign this Agreement, including but  not limited to any claim, action or proceeding relating to Executive’s employment or Executive’s  separation of employment from the Company and/or any of its affiliates and/or any other of the  Released Parties.  Nothing in this Agreement waives or attempts to waive any claims, actions or  proceedings that cannot legally be waived, or any rights the Executive may have to file a charge  of discrimination with a federal or state administrative agency (such as the EEOC or NLRB), or  cooperate, assist, or participate in an investigation, proceeding, or administrative charge before  such agency, provided, however, that the Executive acknowledges and agrees that the Executive  is not entitled to (and hereby waives) any personal recovery or compensation in any such  administrative proceedings, whether brought by Executive or on Executive’s behalf in connection  with Executive’s employment or termination of employment with the Company.   7. Non-Disparagement.  Executive expressly agrees and covenants that he will not  disparage or make negative statements, whether written or oral, publicly or privately, in his own  name or anonymously (or through or with any other person or entity), about the Company, the  Company’s business or business relations, the Company’s operations or business practices, the  Company’s shareholders, officers, directors, Executives or representatives, or any other persons or  entities affiliated with the Company.  Executive will not directly or indirectly cause or direct others  to take any actions or make any statements that violate this Paragraph 7.  Nothing in this Agreement  (including in Paragraph 9 hereof or in this Paragraph 7) prohibits Executive from disclosing,  reporting or making truthful statements about, either internally or to any third party, any allegations  of harassment and/or employment discrimination.   8. No Encouragement of Claims.  Except as provided above in Paragraph 6,  Executive will not encourage or assist any person or entity who files a lawsuit, charge, claim or  complaint against any of the Released Parties unless Executive is required to render such assistance  pursuant to a lawful subpoena or other legal obligation, and, in that event, Executive will provide  the Company with prompt notice of any such asserted legal obligation, and Executive shall not  cooperate unless and until the Company has had a reasonable opportunity to respond and object to  such subpoena or other asserted legal obligation, as the case may be.  For avoidance of doubt,  nothing in this Paragraph 8 shall prohibit Executive from assisting a person who files a charge with  the NLRB.   9. Non-Disclosure of Confidential Information.  Executive agrees and covenants  that (except as may be expressly authorized by the Company) he shall not disclose, discuss, publish  or in any manner communicate, whether directly or indirectly: (i) any “Confidential Information”  about or relating to the Company, including but not limited to any confidential or proprietary  information Executive learned of or received during or as a result of Executive’s employment with  the Company; and/or (ii) any personal, private, non-public, and/or confidential information  concerning or relating to any of the Company’s officers, directors, agents, managers, employees,  clients, the Released Parties, and/or the Company’s other business relationships.  Executive will  not directly or indirectly cause or direct others to take any actions or make any statements that  violate this provision.  Confidential Information shall mean information, material and trade secrets  maintained or received by the Company (including any of the Released Parties), whether or not  owned or developed by the Company, which Executive has obtained knowledge of or access to  through or as a result of the services rendered in relation to Executive’s employment with the  

 

   -7-    Company.  Without in any way limiting the confidentiality restrictions above (or as otherwise  apply under the Illinois Trade Secrets Act, and/or Executive’s existing contractual confidentiality  obligations), “Confidential Information” shall include (but not be limited to) the following types  of information, whether or not reduced to writing or still in development: client data, formulae,  processes, research and development, marketing or promotional information and the methods  thereof, trade secrets including any intellectual property, trademarks, copyrights and patents,  whether registered or unregistered, software, work product, the methods of business operation of  the Company, the names and contact information of its clients and customers, business and  operational documentation, diagrams, flow charts, research, economic and financial analyses,  processes, procedures, “know how,” marketing techniques and material, marketing and business  development plans, customer profiles and historical data, and/or any other information provided  to the Company pursuant to any agreement relating to confidentiality or non-disclosure of a  customer’s proprietary or otherwise confidential information, and/or other non-public information  relating to the Company, its markets, customers, Executives, pricing, financial information, and  other business materials and efforts.   10. Restatement of Post-Employment Covenants.  In consideration of the promises  herein, Executive hereby certifies that he has complied with, and will continue to comply with,  any and all post-employment restrictive covenant agreements Executive has entered into with the  Company, including, but not limited to, any covenants concerning the disclosure of confidential  information, as well as post-employment non-competition and/or non-solicitation covenants by  Executive.  Executive further acknowledges and agrees that the Separation Package constitutes  additional consideration in support of such post-employment restrictive covenants agreements.   Such agreements will expire (if at all) in accordance with their express terms.   11. Confidentiality of Agreement.  Executive agrees (a) to treat this Agreement as  confidential in all respects and (b) except as required by law (after giving prior written notice to  the Company) or as expressly authorized by the Company in writing, not to disclose its existence  or contents to any person or entity other than the tax authorities and Executive’s, accountant and  immediate family, and only after advising such individuals of the confidential nature of this  Agreement and securing their binding promise not to further disclose its existence or contents.   Executive understands that Executive will be responsible for any disclosure that derives from  Executive or from an individual with whom Executive shares the terms of this Agreement.     Executive agrees and acknowledges that the inclusion of the confidentiality clauses in Sections 9  and 11 are Executive’s preference and are mutually beneficial to Executive and the Company.   12. Remedies.  Executive expressly acknowledges and agrees that a violation of the  provisions of Paragraphs 9 and 10 above could result in or cause immediate and irreparable harm,  loss and damage to the Company, which harm likely would not be adequately compensable by a  monetary award.  As such, Executive agrees that the Company has the right to injunctive relief to  enforce and guard against any breach or threatened breach of such paragraphs.  Such injunctive  relief is available in addition to, and not in lieu of, any other remedies available to the Company  at law or in equity, including, without limitation, monetary damages.  Furthermore, such injunctive  relief shall be available to the Company without it posting any bond or security.  Executive also  agrees that the limitations set forth in Paragraphs 9 and 10 are reasonable and are properly required  for the Company’s protection, and in the event that any territorial, time and/or scope limitation is  deemed to be unreasonable by a court of competent jurisdiction, the Company and Executive agree,  

 

   -8-    and Executive hereby submits, to the reduction of any or all of said territorial, time and/or scope  limitations to such an area, period or scope as said court shall deem reasonable under the  circumstances, to the maximum extent permitted by then-existing law.  If such partial enforcement  of any provision (or portion thereof) is not possible, Executive agrees that such provision (or  portion thereof) in question shall be deemed severed and the remaining provisions of this  Agreement shall survive in full force and effect.    13. Return of Property.  Executive will promptly return to the Company any and all  of the Company’s (or the Company’s customers’) property in Executive’s possession, custody or  control, in any form and medium in which Executive has it (whether hard copy, electronic or  otherwise), without retaining any copies, duplications or reproductions.  Such returned property  shall include, without limitation, access cards, keys, computers, laptops, monitors, headsets, wi-fi  adapters, keyboards, credit cards, equipment, software, databases, client and supplier lists,  manuals, disks, files, documents, letters, notes, financial information, and methods of doing  business which Executive received, obtained, had access to or became privy to as a result of  Executive’s employment with the Company, whether or not such items constitute, reflect, or  contain any Confidential Information.  By signing below, Executive certifies that Executive is in  full compliance with this Paragraph 13.   14. No Admission of Liability.  This Agreement does not constitute an admission by  any of the Released Parties that any action that any of them took with respect to Executive was  wrongful, unlawful or in violation of any local, state, federal, or international act, statute, or  constitution, or susceptible of inflicting any damages or injury on Executive, and the Company  specifically denies any such wrongdoing or violation.   15. Breach of Agreement.  If the Company is required to commence or defend an  action in law or equity to enforce its rights under any provision of this Agreement and prevails,  Executive shall be liable for the reasonable attorneys’ fees and costs incurred by the Company in  connection with such action.     16. Severability.  The provisions of this Agreement shall be severable and the  invalidity of any provision shall not affect the validity of the other provisions; provided, however,  that upon any finding by a court of competent jurisdiction that any provision of this Agreement,  including but not limited to, any covenant in Paragraphs 9 and 10 of this Agreement is overbroad,  void or unenforceable, Executive agrees, at the Company’s option, either to execute promptly a  release, waiver and/or covenant that is legal and enforceable or to immediately return to the  Company to the entire Separation Package provided to Executive pursuant to Paragraph 3.   Nothing in this Agreement purports to restrict Executive’s ability to engage in communications  allowable under applicable law.   17. Tolling.  In the event of a breach or violation by Executive of Paragraph 10 of this  Agreement, any restrictive covenants referenced in Paragraph 10 shall be tolled (retroactive to the  date such breach commenced) until such breach or violation has been duly cured.   18. No Oral Waiver / Modification.  The terms of this Agreement may be waived or  modified only in a written document signed both by Executive and by a duly-authorized  representative of the Company.   

 

   -9-    19. Choice of Law and Venue.  This Agreement shall be governed by and interpreted  in accordance with law of the State of Illinois, without regard to the law of conflicts of that State.  The Parties agree that any dispute regarding the enforceability or breach of this Agreement shall  be adjudicated in a federal or state court of competent jurisdiction in Cook County, Illinois.   Executive expressly waives any objections that may be made relative to personal jurisdiction over  Executive in said Illinois courts and submits to the jurisdiction thereof.   20. Compliance with Section 409A of the Code and Treasury Regulations.   a) This Agreement is intended to comply with, or be exempt from, the requirements  of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the Treasury  Regulations and other administrative guidance issued thereunder (“Section 409A”) and shall be  interpreted in a manner consistent with such requirements. Each payment or installment under this  Agreement shall constitute a separate payment for purposes of Section 409A. To the extent that  any amount payable upon termination of employment constitutes “nonqualified deferred  compensation” subject to the requirements of Section 409A, any reference to such termination  shall mean a “separation from service” within the meaning of Section 409A. Subject to any earlier  payment date specified in this Agreement, any reimbursement shall be paid no later than the end  of the calendar year following the calendar year in which the expense was incurred. If, at any time,  Executive is considered a “specified employee” under Treasury Regulation Section 1.409A-1(i),  all payments made under this Agreement shall be paid on the later of: (i) the date identified under  this Agreement; or (ii) the earliest date on which such payment would comply with the  requirements of Section 409A(a)(2)(B)(i) of the Code.   b) With regard to any provision herein that provides for reimbursement of costs and  expenses or in-kind benefits, except as permitted by Section 409A, (A) the right to reimbursement  or in-kind benefits shall not be subject to liquidation or exchange for another benefit, (B) the  amount of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable  year shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in  any other taxable year, provided, that the foregoing clause (B) shall not be violated with regard to  expenses reimbursed under any arrangement covered by Section 105(b) of the Code solely because  such arrangement provides for a limit on the amount of expenses that may be reimbursed over  some or all of the period the arrangement is in effect and (C) such payments shall be made on or  before the last day of Executive’s taxable year following the taxable year in which the expenses  was incurred.   c) The Company shall have no obligation to indemnify, gross up, or otherwise  reimburse Executive for any tax, additional tax, interest, or penalty resulting from any violation of  Section 409A or any corresponding provision of state, local, or foreign law, so long as it has acted  in good faith with regard to compliance therewith.   21. Waiver of Jury Trial. EXECUTIVE HEREBY WAIVES ALL RIGHTS TO  TRIAL BY JURY IN ANY ACTION OR PROCEEDING WHICH PERTAINS DIRECTLY OR  INDIRECTLY TO THIS AGREEMENT OR ANY ADDENDUM OR OTHER AGREEMENT   WHICH, IN ANY WAY, ARISES OUT OF OR RELATES TO EXECUTIVE’S EMPLOYMENT  WITH OR ENGAGEMENT BY THE COMPANY OR ANY OTHER RELATIONSHIP  BETWEEN THE PARTIES.   

 

   -10-    22. Knowing and Voluntary.  Executive acknowledges and agrees that, in addition to  receiving a copy of this Agreement for Executive’s consideration prior to signing:   a) Executive has read and understands each of the terms of this Agreement; and   b) Executive has had an opportunity, and has been advised in writing by this  Agreement to consult with an attorney of Executive’s choosing about the terms of  this Agreement before signing it; and   c) Executive has been given an opportunity to consider this Agreement for up to  twenty-one (21) days before signing it, and that any decision to sign this Agreement  before such 21-day period ends is solely at Executive’s own free choice and  discretion; and   d) Executive is signing this Agreement knowingly and voluntarily, without any duress,  coercion or undue influence and without relying upon any terms or provisions not  expressly stated in this Agreement.   23. Revocation and Effective Date.  Executive understands and acknowledges that  once Executive signs this Agreement, Executive will have seven (7) days to revoke his signature  and agreement to be bound by its terms, by providing written notice of such revocation to the  Company, c/o Mark Monitello, mmonitello@gohealth.com, GoHealth, LLC, 214 West Huron St.,  Chicago, IL 60654.  Executive further understands that this Agreement will become effective, if not  sooner revoked, on the eighth (8th) day after Executive signs it (the “Effective Date”).   24. Entire Agreement.  This Agreement, any restricted stock unit and/or stock option  award agreements referenced in Paragraph 2(b), and any restrictive covenant agreements  referenced in Paragraph 10, contain the entire agreement and understanding between Executive  and the Company concerning all matters contained herein.  This Agreement, any restricted stock  unit and/or stock option award agreements referenced in Paragraph 2(b), and any restrictive  covenant agreements referenced in Paragraph 10, supersede all prior agreements, discussions,  negotiations, understandings and proposals of the Parties relating to the separation of Executive’s  employment from the Company.  The terms of this Agreement, any restricted stock unit and/or  stock option award agreements referenced in Paragraph 2(b), and any restrictive covenant  agreements referenced in Paragraph 10, cannot be changed except in a subsequent document  signed by both Parties.   25. Counterparts.  This Agreement may be executed in counterparts and will be as  fully binding as if signed in one entire document.        WHEREFORE, the Parties execute this Agreement voluntarily and of their own free will          and deed, after due time to review and consider it, and without any duress or coercion, as follows:   

 

   -11-       JAMES SHARMAN   /s/ James Sharman    James Sharman         Date: 6 / 3/2022              NORVAX, LLC   /s/ Brian Farley              Date: 6 / 3/2022         Brian Farley, Chief Legal Officerexhibit106

1      Exhibit 10.6  GOHEALTH,  INC.  NON‐EMPLOYEE  DIRECTOR  COMPENSATION  POLICY    Non‐employee members of  the board of directors  (the “Board”) of GoHealth,  Inc.  (the  “Company”) shall be eligible to receive cash and equity compensation as set forth  in this Non‐  Employee  Director  Compensation  Policy  (this  “Policy”).  The  cash  and  equity  compensation  described in this Policy shall be paid or be made, as applicable, automatically and without further  action of the Board, to each member of the Board who is not an employee of the Company or any  parent or subsidiary of the Company (each, a “Non‐Employee Director”) who may be eligible to  receive such cash or equity compensation, unless such Non‐Employee Director declines the receipt  of such cash or equity compensation by written notice to the Company.    This Policy shall become effective after the effectiveness of the Company’s  initial public  offering (the “IPO”) and shall remain in effect until it is revised or rescinded by further action of  the Board. This Policy may be amended, modified or terminated by the Board at any time in its  sole discretion.  The  terms and conditions of  this Policy shall supersede any prior cash and/or  equity compensation arrangements for service as a member of the Board between the Company  and any of its Non‐Employee Directors and between any subsidiary of the Company and any of its  non‐employee directors.  Notwithstanding  the  foregoing, any member of  the Board who  is an  employee of Centerbridge Partners L.P. is not eligible for and shall not receive any compensation  under this Policy.    1. Cash Compensation.    (a) Annual  Retainers.  Each Non‐Employee Director  shall  receive  an  annual  retainer of $150,000 for service on the Board.    (b) Payment of Retainers.  The annual retainers described in Section 1(a) shall  be earned on a quarterly basis based on a calendar quarter and shall be paid by the Company in  arrears not later than the fifteenth day following the end of each calendar quarter.  In the event  a  Non‐Employee Director does  not  serve  as  a Non‐Employee Director  for  an  entire  calendar  quarter, such Non‐Employee Director shall receive a prorated portion of the retainer otherwise  payable to such Non‐Employee Director for such calendar quarter pursuant to Section 1(a), with  such prorated portion determined by multiplying such otherwise payable retainer by a fraction,  the numerator of which is the number of days during which the Non‐Employee Director serves as  a Non‐Employee Director during the applicable calendar quarter and the denominator of which is  the number of days in the applicable calendar quarter.    2. Equity Compensation. Non‐Employee Directors shall be granted the equity awards  described below.  The awards described below shall be granted under and shall be subject to the  terms  and  provisions  of  the  Company’s  2020  Incentive  Award  Plan  or  any  other  applicable  Company equity incentive plan then‐maintained by the Company (such plan, as may be amended  from time to time, the “Equity Plan”) and shall be granted subject to the execution and delivery  of award agreements,  including attached exhibits,  in  substantially  the  forms approved by  the  

 

2      Board. All applicable terms of the Equity Plan apply to this Policy as if fully set forth herein, and all  equity grants hereunder are subject in all respects to the terms of the Equity Plan.  (a) IPO Awards.  Each Non‐Employee Director who (i) serves on the Board as of  the  date  the  IPO  price  of  the  shares  of  the  Company’s  common  stock  (the  “IPO  Price”)  is  established  in connection with the Company’s IPO (the “Pricing Date”) and (ii) will continue to  serve as a Non‐Employee Director immediately following the Pricing Date shall be automatically  granted, on the Pricing Date, an award of restricted stock units that have an aggregate fair value  on  the  date  of  grant  of  $150,000  for  each  Non‐Employee  Director  who  does  not  serve  as  Chairperson or Co‐Chairperson of  the Board or of any committee of  the Board or as  the Lead  Director  of  the  Board  (a  “Non‐Chairperson Director”)  and  $250,000  for  each Non‐Employee  Director who serves as the Chairperson or Co‐Chairperson of the Board or of any committee of  the  Board  or  as  the  Lead Director  of  the  Board  (in  each  case,  a  “Chairperson Director”)  (as  determined in accordance with FASB Accounting Codification Topic 718 (“ASC 718”) and subject  to adjustment as provided in the Equity Plan in each case).  The awards described in this Section  2(a) shall be referred to herein as the “IPO Awards”).    (b) Annual Awards. Each Non‐Employee Director who (i) serves on the Board as  of the date of any annual meeting of the Company’s stockholders (an “Annual Meeting”) after the  Pricing Date and (ii) will continue to serve as a Non‐Employee Director immediately following such  Annual Meeting shall be automatically granted, on the date of such Annual Meeting, an award of  restricted stock units that have an aggregate fair value on the date of grant of $150,000 for Non‐  Chairperson Directors and $250,000 for Chairperson Directors (as determined in accordance with  ASC 718 and subject to adjustment as provided in the Equity Plan).  The awards described in this  Section 2(b) shall be referred to as the “Annual Awards.”  For the avoidance of doubt, a Non‐ Employee Director elected for the first time to the Board at an Annual Meeting shall receive only  an Annual Award in connection with such election, and shall not receive any Initial Award on the  date of such Annual Meeting as well.    (c) Initial Awards.  Except as otherwise determined by the Board, each Non‐  Employee Director who is initially elected or appointed to the Board after the Pricing Date on any  date other than the date of an Annual Meeting shall be automatically granted, on the date of such  Non‐Employee Director’s  initial election or appointment  (such Non‐Employee Director’s “Start  Date”), an award of restricted stock units that have an aggregate fair value on such Non‐Employee  Director’s  Start Date  equal  to  the product of  (i)  $150,000  for Non‐Chairperson Directors  and  $250,000 for Chairperson Directors  (as determined  in accordance with ASC 718) and (ii) a fraction, the  numerator of which  is (x) 365 minus (y) the number of days  in the period beginning on the date of the  Annual Meeting  immediately preceding such Non‐Employee Director’s Start Date (or,  if no such Annual  Meeting  has  occurred,  the  effective  date  of  the  Company’s  IPO)  and  ending  on  such Non‐Employee  Director’s Start Date and the denominator of which is 365 (with the number of shares of common stock  underlying each such award subject to adjustment as provided in the Equity Plan).  The awards described  in this Section 2(c) shall be referred to as “Initial Awards.”  For the avoidance of doubt, no Non‐Employee  Director shall be granted more than one Initial Award.    (d) Termination of Employment of Employee Directors. Members of the Board  who are employees of the Company or any parent or subsidiary of the Company who subsequently  terminate their employment with the Company and any parent or subsidiary of the Company and  

 

3      remain on the Board will not receive an Initial Award pursuant to Section 2(c) above, but to the  extent  that  they  are  otherwise  eligible,  will  be  eligible  to  receive,  after  termination  from  employment with the Company and any parent or subsidiary of the Company, Annual Awards as  described in Section 2(b) above.    (e) Vesting of Awards Granted to Non‐Employee Directors.  Each  IPO Award  shall  vest  and  become  exercisable  in  four  equal  installments  on  the  first  four  quarterly  anniversaries of the date of grant, subject to the Non‐Employee Director continuing in service on  the Board through the applicable vesting date, and each Annual Award and Initial Award shall vest  and become exercisable in four equal installments on the first four quarterly anniversaries of the  date of grant, subject to the Non‐Employee Director continuing in service on the Board through the  applicable  vesting date; provided, however,  that, notwithstanding  the  foregoing, each Annual  Award and Initial Award shall vest and become exercisable in its entirety on the day immediately  preceding the date of the first Annual Meeting following the date of grant, subject to the Non‐  Employee Director continuing in service on the Board through such date.  No portion of an IPO  Award, Annual Award or  Initial Award that  is unvested or unexercisable at the time of a Non‐  Employee Director’s  termination of service on  the Board shall become vested and exercisable  thereafter.  All of a Non‐Employee Director’s IPO Awards, Annual Awards and Initial Awards shall  vest in full immediately prior to the occurrence of a Change in Control (as defined in the Equity  Plan), to the extent outstanding at such time.    3. Expenses    The Company will reimburse each Non‐Employee Director for ordinary, necessary  and reasonable out‐of‐pocket travel expenses to cover in‐person attendance at and participation  in Board meetings and meetings of any committee of the Board; provided, that the Non‐Employee  Director timely submit to the Company appropriate documentation substantiating such expenses  in accordance with the Company’s travel and expense policy applicable to directors, as in effect  from  time  to  time. To  the extent  that any  taxable  reimbursements are provided  to any Non‐  Employee Director, they will be provided in accordance with Section 409A of the Internal Revenue  Code of 1986, as amended, including, but not limited to, the following provisions: (i) the amount  of any such expenses eligible for reimbursement during such  individual’s taxable year may not  affect the expenses eligible for reimbursement in any other taxable year; (ii) the reimbursement  of an eligible expense must be made no later than the last day of such individual’s taxable year  that immediately follows the taxable year in which the expense was incurred; and (iii) the right to  any reimbursement may not be subject to liquidation or exchange for another benefit.    * * * * *  Updated September 2021

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]